BACKGROUND: Depression increases the risk of subsequent vascular events in both cardiac and non-cardiac patients. Atherosclerosis, the underlying process leading to vascular events, has been associated with depression. This association, however, may be confounded by the somatic-affective symptoms being a consequence of cardiovascular disease. While taking into account the differentiation between somatic-affective and cognitive-affective symptoms of depression, we examined the association between depression and atherosclerosis in a community-based sample. METHOD: In 1261 participants of the Nijmegen Biomedical Study (NBS), aged 50-70 years and free of stroke and dementia, we measured the intima-media thickness (IMT) of the carotid artery as a measure of atherosclerosis and we assessed depressive symptoms using the Beck Depression Inventory (BDI). Principal components analysis (PCA) of the BDI items yielded two factors, representing a cognitive-affective and a somatic-affective symptom cluster. While correcting for confounders, we used separate multiple regression analyses to test the BDI sum score and both depression symptom clusters. RESULTS: We found a significant correlation between the BDI sum score and the IMT. Cognitive-affective, but not somatic-affective, symptoms were also associated with the IMT. When we stratified for coronary artery disease (CAD), the somatic-affective symptom cluster correlated significantly with depression in both patients with and patients without CAD. CONCLUSIONS: The association between depressive symptoms and atherosclerosis is explained by the somatic-affective symptom cluster of depression. Subclinical vascular disease thus may inflate depressive symptom scores and may explain why treatment of depression in cardiac patients hardly affects vascular outcome.
BACKGROUND:Depression increases the risk of subsequent vascular events in both cardiac and non-cardiac patients. Atherosclerosis, the underlying process leading to vascular events, has been associated with depression. This association, however, may be confounded by the somatic-affective symptoms being a consequence of cardiovascular disease. While taking into account the differentiation between somatic-affective and cognitive-affective symptoms of depression, we examined the association between depression and atherosclerosis in a community-based sample. METHOD: In 1261 participants of the Nijmegen Biomedical Study (NBS), aged 50-70 years and free of stroke and dementia, we measured the intima-media thickness (IMT) of the carotid artery as a measure of atherosclerosis and we assessed depressive symptoms using the Beck Depression Inventory (BDI). Principal components analysis (PCA) of the BDI items yielded two factors, representing a cognitive-affective and a somatic-affective symptom cluster. While correcting for confounders, we used separate multiple regression analyses to test the BDI sum score and both depression symptom clusters. RESULTS: We found a significant correlation between the BDI sum score and the IMT. Cognitive-affective, but not somatic-affective, symptoms were also associated with the IMT. When we stratified for coronary artery disease (CAD), the somatic-affective symptom cluster correlated significantly with depression in both patients with and patients without CAD. CONCLUSIONS: The association between depressive symptoms and atherosclerosis is explained by the somatic-affective symptom cluster of depression. Subclinical vascular disease thus may inflate depressive symptom scores and may explain why treatment of depression in cardiac patients hardly affects vascular outcome.
Authors: Radboud M Marijnissen; Lonneke Wouts; Robert A Schoevers; Marijke A Bremmer; Aartjan T F Beekman; Hannie C Comijs; Richard C Oude Voshaar Journal: Neurology Date: 2014-10-01 Impact factor: 9.910
Authors: Elmar Brähler; Manfred E Beutel; Ana N Tibubos; Daniëlle Otten; Daniela Zöller; Harald Binder; Philipp S Wild; Toni Fleischer; Hamimatunnisa Johar; Seryan Atasoy; Lara Schulze; Karl-Heinz Ladwig; Georg Schomerus; Birgit Linkohr; Hans J Grabe; Johannes Kruse; Carsten-Oliver Schmidt; Thomas Münzel; Jochem König Journal: BMC Psychiatry Date: 2021-05-05 Impact factor: 3.630
Authors: Nynke A Groenewold; Bennard Doornbos; Marij Zuidersma; Nicole Vogelzangs; Brenda W J H Penninx; André Aleman; Peter de Jonge Journal: PLoS One Date: 2013-01-14 Impact factor: 3.240
Authors: Matthias Michal; Jörg Wiltink; Yvonne Kirschner; Philipp S Wild; Thomas Münzel; Francisco M Ojeda; Tanja Zeller; Renate B Schnabel; Karl Lackner; Maria Blettner; Isabella Zwiener; Manfred E Beutel Journal: PLoS One Date: 2013-08-13 Impact factor: 3.240